Testing effectiveness (Phase 2)Study completedNCT03500263
What this trial is testing
Safety, Tolerability, and Pharmacokinetics of PTI-808, PTI-801, and PTI-428 Combination Therapy in Subjects With Cystic Fibrosis
Who this might be right for
Cystic Fibrosis
Proteostasis Therapeutics, Inc. 12